Mark A Jones (Mark Jones)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Top Venues

Healthcare (Basel, Switzerland)

Ophthalmic epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Parveen Fathima, Mark A Jones, Reena D'Souza, James A Totterdell, Nada Andric, Penelope A Abbott, Richard Norman, Kirsten Howard, Wendy Cheng, Alisa E Pedrana, Joseph S Doyle, Jane Davies, Thomas L Snelling
Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study. Trials 25 (1) (2024)
Parveen Fathima, Mark A Jones, Reena D'Souza, James A Totterdell, Nada Andric, Penelope A Abbott, Richard Norman, Kirsten Howard, Wendy Cheng, Alisa E Pedrana, Joseph S Doyle, Jane Davies, Thomas L Snelling
Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study. Trials 25 (1) (2024)
Parveen Fathima, Mark A Jones, Reena D'Souza, James A Totterdell, Nada Andric, Penelope A Abbott, Richard Norman, Kirsten Howard, Wendy Cheng, Alisa E Pedrana, Joseph S Doyle, Jane Davies, Thomas L Snelling
Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study. Trials 25 (1) (2024)
Meg J Jardine, Sradha S Kotwal, Abhinav Bassi, Carinna Hockham, Mark A Jones, Arlen Wilcox, Carol A Pollock, Louise M Burrell, Vijay S Rathore, Christine R Jenkins, Lalit Gupta, Angus Graham Ritchie, Ashpak Bangi, Sanjay D'Cruz, Andrew J McLachlan, Simon R Finfer, Michelle M Cummins, Thomas L Snelling, Vivekananda Jha, null null
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial. BMJ (Clinical research ed.) 379 (2022)
Kim Edmunds, Penny Reeves, Paul A Scuffham, Daniel A Galvão, Robert U Newton, Mark A Jones, Nigel A Spry, Dennis R Taaffe, David Joseph, Suzanne K Chambers, Haitham W Tuffaha
Cost-Effectiveness Analysis of Supervised Exercise Training in Men with Prostate Cancer Previously Treated with Radiation Therapy and Androgen-Deprivation Therapy. Applied health economics and health policy 18 (5) (2021)
Mark A Jones, Clare Whitton, Ava G Tan, Elizabeth G Holliday, Christopher Oldmeadow, Victoria M Flood, Xueling Sim, Jin-Fang Chai, Haslina Hamzah, Ronald Klein, Yik-Ying Teo, Paul Mitchell, Tien Y Wong, E Shyong Tai, Rob M Van Dam, John Attia, Jie Jing Wang
Exploring Factors Underlying Ethnic Difference in Age-related Macular Degeneration Prevalence. Ophthalmic epidemiology 27 (5) (2020)
Bianca Fleur Middleton, Margie Danchin, Helen Quinn, Anna P Ralph, Nevada Pingault, Mark A Jones, Marie Estcourt, Tom Snelling
Retrospective Case-Control Study of 2017 G2P[4] Rotavirus Epidemic in Rural and Remote Australia. Pathogens (Basel, Switzerland) 9 (10) (2020)
Mark A Jones, Todd Graves, Bianca Middleton, James Totterdell, Thomas L Snelling, Julie A Marsh
The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan. Trials 21 (1) (2020)
Bianca Fleur Middleton, Mark A Jones, Claire S Waddington, Margaret Danchin, Carly McCallum, Sarah Gallagher, Amanda Jane Leach, Ross Andrews, Carl Kirkwood, Nigel Cunliffe, Jonathan Carapetis, Julie A Marsh, Tom Snelling
The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis. BMJ open 9 (11) (2019)
Marianne J Mullane, Timothy C Barnett, Jeffrey W Cannon, Jonathan R Carapetis, Ray Christophers, Juli Coffin, Mark A Jones, Julie A Marsh, Frieda Mc Loughlin, Vicki O'Donnell, Rebecca Pavlos, Bec Smith, Andrew C Steer, Steven Y C Tong, Roz Walker, Asha C Bowen
SToP (See, Treat, Prevent) skin sores and scabies trial: study protocol for a cluster randomised, stepped-wedge trial for skin disease control in remote Western Australia. BMJ open 9 (9) (2019)
Melinda Jane Hutchesson, Robin Callister, Philip James Morgan, Ilung Pranata, Erin D Clarke, Geoff Skinner, Lee M Ashton, Megan C Whatnall, Mark A Jones, Christopher Oldmeadow, Clare E Collins
A Targeted and Tailored eHealth Weight Loss Program for Young Women: The Be Positive Be Healthe Randomized Controlled Trial. Healthcare (Basel, Switzerland) 6 (2) (2018)